| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Operating Officer
1 company
Deschatelets Pascal is a Chief Scientific Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $48.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 4,000 | $44.43 | $177,720.00 | -0.4% | +31.6% | +91.7% | |
| Jun 24, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 6,250 | $65.61 | $410,062.50 | -0.7% | -48.6% | -26.7% | |
| May 24, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 6,250 | $47.40 | $296,250.00 | -0.7% | +31.0% | -9.9% | |
| Apr 23, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 6,250 | $46.13 | $288,312.50 | -0.7% | +48.2% | +9.1% | |
| Mar 10, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 6,250 | $50.74 | $317,125.00 | -0.7% | +13.5% | -9.2% | |
| Feb 13, 2020 | APLS Apellis Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 107,473 | $41.86 | $4,499,120.87 | -5.2% | - | - | |
| Sep 25, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 21,541 | $25.26 | $544,058.79 | -1.2% | - | - | |
| Sep 24, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 42,460 | $24.82 | $1,053,995.38 | -1.1% | - | - |